These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 32852767

  • 1. A Circulating MicroRNA Panel for Malignant Germ Cell Tumor Diagnosis and Monitoring.
    Murray MJ, Scarpini CG, Coleman N.
    Methods Mol Biol; 2021; 2195():225-243. PubMed ID: 32852767
    [Abstract] [Full Text] [Related]

  • 2. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.
    Bell E, Watson HL, Bailey S, Murray MJ, Coleman N.
    Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, Dieckmann KP.
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis.
    Piao J, Lafin JT, Scarpini CG, Nuño MM, Syring I, Dieckmann KP, Belge G, Ellinger J, Amatruda JF, Bagrodia A, Coleman N, Krailo MD, Frazier AL, Murray MJ.
    Clin Genitourin Cancer; 2021 Dec; 19(6):469-479. PubMed ID: 34629299
    [Abstract] [Full Text] [Related]

  • 8. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
    Murray MJ, Bell E, Raby KL, Rijlaarsdam MA, Gillis AJ, Looijenga LH, Brown H, Destenaves B, Nicholson JC, Coleman N.
    Br J Cancer; 2016 Jan 19; 114(2):151-62. PubMed ID: 26671749
    [Abstract] [Full Text] [Related]

  • 9. Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting.
    Ye F, Feldman DR, Valentino A, So R, Bromberg M, Khan S, Funt SA, Sheinfeld J, Solit DB, Pessin MS, Peerschke EI.
    J Mol Diagn; 2022 Aug 19; 24(8):867-877. PubMed ID: 35934321
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical utility of plasma miR-371a-3p in germ cell tumors.
    Mego M, van Agthoven T, Gronesova P, Chovanec M, Miskovska V, Mardiak J, Looijenga LHJ.
    J Cell Mol Med; 2019 Feb 19; 23(2):1128-1136. PubMed ID: 30536846
    [Abstract] [Full Text] [Related]

  • 18. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
    Fankhauser CD, Christiansen AJ, Rothermundt C, Cathomas R, Wettstein MS, Grossmann NC, Grogg JB, Templeton AJ, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T.
    Br J Cancer; 2022 May 19; 126(8):1140-1144. PubMed ID: 34912073
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.